Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. ACCESSWIRE +5.74%. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. Trading. UBX1325 Phase 1 initial data expected 1H 2021. View institutional ownership trends for Virpax Pharmaceuticals. (VRPX) raised $15 million in an initial public offering (IPO) on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO. The company’s stock price has collected 12.53% of gains in the last five trading sessions. VRPX: Get the latest Virpax Pharmaceuticals stock price and detailed information including VRPX news, historical charts and realtime prices. Their latest funding was raised on Feb 16, 2021 from a Series C round. Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) loss -5.26% – Is It right time to buy? Data is currently not available. Monday, April 05, 2021. Topical metered-dose spray. NASDAQ 1.10%. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax ® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, … Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 09:00 AM ET. DOW 0.03%. Phone Number 610.727.4597. The company belongs in the Biotechnology industry, Healthcare sector and … Free forex prices, toplists, indices and lots more. Nasdaq 100. 2.13 “Company” means Virpax Pharmaceuticals, Inc., a Delaware corporation, and any successor thereto as provided in Section 16.8. The company is focused on developing pharmaceutical product candidates for pain management. Virpax Pharmaceuticals' lock-up period expires on Monday, August 16th. Virpax Pharmaceuticals had issued 1,800,000 shares in its initial public offering on February 17th. The total size of the offering was $18,000,000 based on an initial share price of $10.00. The stock’s 5-day price performance is 7.95%, and it has moved by 19.35% in 30 days. April 9, 2021 Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $6.00 to be very precise. PRICE ACTION $4.50. Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Nasdaq Listed. Name Role Date Shares Price Value; Gary S. Jacob: Director: 2021-02-17: 3,500: $6.79: $23.76k Buy. Rolontis PDUFA date was 10/24/20. Virpax Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. Please refer to the Stock Price Adjustment Guide for more information on our historical prices. Which institutional investors are buying Virpax Pharmaceuticals stock? Virpax Pharmaceuticals Inc. (VRPX) registered a 1.00% upside in the last session and has traded in the green over the past 5 sessions. 09:00 AM ET. Virpax Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Virpax Pharmaceuticals stock? The Stock rose vividly during the last session to $5.22 after opening rate of $4.376 while the lowest price it went was recorded $4.2649 before closing at $4.41. Monday, April 19, 2021. The Company is focused on developing pharmaceutical product candidates for pain management by developing and delivering non-opioid and non-addictive pharmaceutical products. Virpax Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. Access our live advanced interactive Virpax Pharmaceuticals Inc stock chart. JUN 11 02:40:13pm VRPX. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in … Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. N/A. Virpax has licensed a patented metered-dose spray system that delivers active pharmaceutical ingredients (API). Stock analysis for Virpax Pharmaceuticals Inc (VRPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. Poziotinib Phase 2 cohort 3 data did not meet primary endpoint – 12/22/20. Buy. One share of VRPX stock can currently be purchased for approximately $3.97. How much money does Virpax Pharmaceuticals make? Virpax Pharmaceuticals has a market capitalization of $19.63 million. Get the hottest s The company was founded by Anthony P. Mack on May 12, 2017 and and is … Virpax Pharmaceuticals (NASDAQ:VRPX) and Galmed Pharmaceuticals (NASDAQ:GLMD) are both small-cap medical companies, but which is the superior stock?We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings. Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. Sell. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is registered under the ticker NASDAQ:VRPX . Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of an animal study model for MMS019, its anti-viral product candidate for respiratory viruses. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Other Notable StockTweets About VRPX. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 12.44% from its latest closing price compared to the recent 1-year high of $8.24. Research its history to confirm it's a solid investment against your financial goals. February 19, 2021 - 4:07 pm. Before founding VIRPAX in 2016, Mr. Mack founded SCILEX Pharmaceuticals and served as President and CEO until ZTlido was approved in February 2018. ACCESSWIRE +5.74%. Find out which indices include the Virpax Pharmaceuticals Inc stock. LAST PRICE - 02:40pm VRPX is trading DOWN -$-0.25 or -5.3% from yesterday's close of $4.75. Commissions Margin Rates Interest Rates Research and News Market Data Stock Yield Enhancement Program Other Fees. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross … Virpax Pharmaceuticals Inc. advanced stock charts by MarketWatch. VIRPAX PHARMACEUTICALS, INC. View Virpax Pharmaceuticals stock trends here About VRPX Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Virpax Pharmaceuticals, Inc. Common Stock, also called Virpax Pharmaceuticals, is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Get the latest Virpax Pharmaceuticals, Inc. VRPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania. Overview Earnings Dividend Ownership. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. With your account you will as well have access to charting tools, advanced order types, leveraged trading and 24-hour global client support. VRPX Preferred Stock as of today (May 25, 2021) is $0.00 Mil. Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $5.14 to be very precise. Learn about the SCoRE. Buy immediately with a market order or use a limit order to delay your purchase until Virpax Pharmaceuticals reaches your desired price. Press Release reported 1 hour ago that Virpax Announces Results of Probudur(TM) in Animal Study. Virpax Announces Results of Probudur(TM) in Animal Study ACCESSWIRE. After your fiat currency strikes your account, you will be able to buy stock from Williams Companies (WMB). Insider buying vs selling Have Virpax Pharmaceuticals Inc insiders been buying or selling? The current RSI for VRPX stock in for the last two-week period is set at 58.51, with the RSI for the last a single of trading hit 66.87, and the three-weeks RSI is set at 53.13 for Virpax Pharmaceuticals Inc. [VRPX], while it was recorded at 5.08 for the last single week of trading.